FindTrial
Sign In

Metal ion levels in patients with indigenous tumor prosthesis.

A Prospective study to evaluate metal ion levels after tumor endoprosthesis (MITE) - MITE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086472
Enrollment
20
Registered
2025-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C419- Malignant neoplasm of bone and articular cartilage, unspecified Health Condition 2: T849- Unspecified complication of internal orthopedic prosthetic device, implant and graft

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Tumor endoprostheses in situ scheduled for revision or new tumor endoprosthesis planned after tumor removal. 2. Ability to give informed consent in English, Hindi or Marathi. 3. Age greater than 18 years.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to give consent for the study.

Design outcomes

Primary

MeasureTime frame
To measure serum chromium and cobalt levels.Timepoint: At baseline—

Secondary

MeasureTime frame
Time since implantation of index tumor prosthesisTimepoint: Index surgery to baseline—

Countries

India

Contacts

Public ContactPrakash Radhakrishna Nayak

Tata Memorial Hospital

nayakprakash@gmail.com24177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026